NEW YORK--(BUSINESS WIRE)--WhizAI, a marketing and sales enablement AI company, today announced that it has joined the NVIDIA Inception program, which is designed to nurture startups revolutionizing industries with advancements in AI and data sciences.
WhizAI offers an AI powered marketing and sales enablement platform for large enterprises. The company’s clients in manufacturing and life sciences are using the whiz platform to increase rep productivity, institutionalize sales best practices, empower marketing with AI powered analytics, and improve adoption of existing data and applications by providing seamless access in natural language on desktop and mobile. A proprietary AI platform, whiz is built for large enterprises and can be deployed within the client’s firewall, integrated with multiple data sources, as well as maintained and customized by the IT team.
The NVIDIA Inception program will benefit WhizAI by providing leading-edge customizable resources in artificial intelligence, deep learning and data science and access to its global network of deep learning experts and thought leaders to accelerate adoption of WhizAI’s marketing and sales enablement platform in key industries including life sciences, manufacturing, and financial services.
“We’re thrilled to join the coveted list of startups in the NVIDIA Inception program, which supports our vision of simplifying and streamlining access to enterprise information anytime, anywhere,” said Rohit Vashisht, co-founder and CEO of WhizAI. “The collaboration with NVIDIA will support our goals for expansion into new markets and help ensure our AI offering continues to be ahead of the curve in the enterprise software market.
”NVIDIA’s Inception program is a virtual accelerator program that helps startups during critical stages of product development, prototyping and deployment. Every Inception member gets a custom set of ongoing benefits, from hardware grants and marketing support to training with deep learning experts.
About WhizAI: WhizAI is empowering commercial teams with its AI-powered marketing and sales enablement platform for large enterprises. We do this by providing seamless access to enterprise data, insights and workflows in natural language on desktop and mobile for improving marketing effectiveness and streamlining sales processes. Our proprietary AI platform is transforming industries to increase rep productivity, institutionalize sales best practices, empower marketing with AI-powered analytics, and improve adoption of existing data and applications.
People also viewed
2022 PMSA Fall Symposium
2022 PMSA FALL SYMPOSIUM October 27 – 28, 2022 Caesars Palace, Las Vegas, Nevada
Customer Centricity and Digital Experiences which are Redefining Pharma
It is no secret that the pharmaceutical industry has historically flourished from blockbuster products with substantial brand equity, favorable pricing
Awash in Data, Yet Starving for Insights? Transform Life Sciences Commercial Teams with AI-Powered Analytics
Personalized communication is something the HCPs have come to expect. To do that, pharma sales reps need to know their customers well. In order to know the customer well, they need data. Enterprise pharma companies, however, have many data resources and lots of data at their disposal. In fact, there is a data explosion. So what do you do?
Augmented Analytics is “On the Rise” on Gartner’s 2022 Hype Cycle for Life Science Commercial Operations
The Gartner® 2022 Hype Cycle™ for Life Science Commercial Operations introduces a new category, Augmented Analytics, this year. WhizAI is listed as a sample vendor in the Augmented Analytics category in this Hype Cycle. This summary report covers the following highlights.
Where Gartner Positions Natural Language Query on the Hype Cycle and What It Means for Life Sciences
Gartner® 2022 Hype Cycle™ for Natural Language Technologies (NLT) shows natural language query (NLQ) adoption is accelerating. WhizAI was recently recognized as a Sample Vendor in the Natural Language Query category in several Gartner Hype Cycles:
AI Powered Business Intelligence for Life Science Leaders: Save Time, Drive Adoption and Scale Faster
Today’s commercial teams must pinpoint top opportunities in markets across the country—or across the world—based on regulations, drug trials, market activity, competitors, insurance records, HCP preferences and affiliations, much more data than is humanly possible to manage.